DUBLIN, Feb 21, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Markets for Generic Drugs" report to their offering.
The report includes an overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD.
It analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021. It also includes an examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by originator companies to forestall generic competition.
This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed by the most important national markets. The nature and structure of the generics industry is discussed, with profiles of the leading 20+ generics companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.
Key Topics Covered:
4: The New Generics Era
5: Major Generic Issues
6: The Generics Market
7: Generics Markets And Forecasts By Country
8: The Global Generics Industry
For more information about this report visit http://www.researchandmarkets.com/research/t887vb/global_markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-markets-for-generic-drugs-2015-2021---includes-coverage-of-antibacterials-antidepressants-anticancer-agents-cardiovascular-drugs--drugs-for-respiratory-conditions---research-and-markets-300410517.html
SOURCE Research and Markets